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ABSTRACT 
As per the mixed solvency concept, every substance present in this universe has got solubilizing power. The substance may be a gas, 
liquid or solid. The present research work is an attempt to demonstrate the solubilizing property of solids. Also, the present research 
work is one of the examples which prove that solids can also be employed for spectrophotometric analysis of poorly soluble drugs in 
place of organic solvents. Tinidazole has got poor solubility in distilled water, while, significantly high solubility in a eutectic liquid 
of two solids, namely, phenol and lignocaine hydrochloride. Phenol and lignocaine hydrochloride were employed in 4:1 ratio to give 
eutectic liquid (PL 41). This eutectic liquid was employed to act as solvent to extract out the drug, tinidazole, from the fine powder 
of its tablets for spectrophotometric estimation at 318 nm. Necessary dilutions were done using distilled water. The solubility of 
tinidazole in distilled water is 5.38 mg/ml at room temperature while the approximate solubility in PL 41 is more than 200 mg/ml. 
Proposed method is novel, accurate, rapid and free from toxicity of organic solvents and reproducible. Recovery studies and 
statistical data proved the accuracy, reproducibility and precision of the analytical method employed. Tablet excipients together with 
phenol and lignocaine hydrochloride did not interfere at 318 nm.  
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INTRODUCTION  
Most frequently employed common techniques of 
solubility enhancement include cosolvency, hydrotropy, 
micellar solubilization, complexation, pH modification 
and salt formation. A novel technique of solubility 
enhancement by use of mixed solvency concept has 
been proposed by Maheshwari 
1-6
. All the substances 
(whether liquids, gases or solids) have solubilizing 
power. Innumerable solvent systems may be developed 
using mixed solvency concept. By application of mixed 
solvency concept 
7-17
, the drug loading in various 
pharmaceutical formulations, including NDDS, may be 
improved and by combining the excipients in 
appropriate amounts, synergistic solvent actions and 
additive solvent actions can be obtained and also the 
problem of toxicity issue due to high concentration of a 
solvent for desired solubility of the drug can be solved. 
Maheshwari 
5
 utilized mixed solvency concept to 
potentiate the solvent character of a weaker solvent. In 
this research work it has been shown that a weaker 
solvent can be made a strong solvent by incorporation of 
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a solid solubilizer. The solubility of frusemide in ethanol 
was enhanced about three fold in the presence of 15% 
w/v niacinamide (a solid solubilizer). Frusemide is 
sparingly soluble in ethanol and pharmacopoeial method 
requires dimethyl formamide (a class II organic solvent) 
for titrimetric analysis of frusemide bulk drug. In this 
research work 15% w/v solution of niacinamide in 
ethanol was successfully employed to carry out 
titrimetric analysis of frusemide bulk drug, giving an 
ecofriendly method of analysis because ethanol is a 
class III organic solvent (relatively safe in comparison 
to dimethyl formamide). The solubilities of a large 
number of poorly soluble drugs have been nicely 
improved utilizing the mixed solvency concept 
1-30
.  
Several organic solvents are employed for 
spectrophotometric analysis of dosage forms of poorly 
water soluble drugs. Methanol, ethanol, chloroform, 
acetonitrile, dichloromethane, dimethyl formamide, 
ethyl acetate, toluene, carbon tetrachloride, acetone and 
hexane are the most common examples of such solvents. 
High cost, toxicity and pollution are serious drawbacks 
of organic solvents. The present investigation is an 
attempt to show that solids can also be wisely employed 
for spectrophotometric estimation of poorly soluble 
drugs without using the organic solvents. 
Present study describes the application of solvent 
character of eutectic liquid (PL 41) of two solid 
solubilizers, namely, phenol and lignocaine 
hydrochloride for spectrophotometric estimation of 
tinidazole tablets. Tinidazole has got poor solubility in 
distilled water while very high solubility in a eutectic 
liquid of two solids, namely phenol and lignocaine 
hydrochloride. Phenol and lignocaine hydrochloride 
were employed in 4:1 ratio to give eutectic liquid, PL 
41. This liquid was used to act as solvent to extract out 
the drug, tinidazole, from the fine powder of its tablets 
for spectrophotometric estimation at 318 nm. Distilled 
water was used for dilution purpose. The solubility of 
tinidazole in distilled water is 5.38 mg/ml at room 
temperature while the approximate solubility in PL 41 is 
more than 200 mg/ml. Proposed method is novel, 
accurate, rapid and free from toxicity of organic solvents 
and reproducible. Recovery studies and statistical data 
proved the accuracy, reproducibility and precision of the 
proposed method. There was no interference of tablet 
excipients, phenol and lignocaine hydrochloride at 318 
nm.  
MATERIALS AND METHODS 
 The gift sample of tinidazole bulk drug was 
procured from M/S Alkem Laboratories Limited, 
Mumbai (India). Chemicals used were of analytical 
grade.  
 Commercial tablets of tinidazole were purchased 
from the local market. 
 A Shimadzu-1700 UV visible spectrophotometer 
with 1 cm matched silica cells was used for 
spectrophotometric analysis. 
1. Preparation of eutectic liquid  
Phenol crystals and lignocaine hydrochloride powder 
were triturated with the help of pestle and mortar in 4:1 
ratio on weight basis to obtain a eutectic liquid, PL 41.  
2. Calibration curve  
To a 500 ml volumetric flask, accurately weighed 50 mg 
of tinidazole standard drug sample was transferred. 
Eutectic liquid, PL 41 (10 ml) was transferred to this 
volumetric flask and the volumetric flask was shaken for 
few minutes to obtain a clear solution. Now 400 ml of 
distilled water was added and the flask was shaken for 
about 5 minutes to get a clear solution. Sufficient of 
distilled water was added to make up the volume to 500 
ml. In this way a stock solution of drug (100 µg/ml) was 
obtained. After suitable dilutions with distilled water, 
the standard solutions containing 10, 20, 30 and 40 
µg/ml of drug were prepared. Calibration curve was 
obtained by using the absorbance of these standard 
solutions, measured against their respective reagent 
blanks at 318 nm. 
3. Preliminary solubility studies 
The equilibrium solubility of drug in distilled water was 
determined. For this, excess amount of drug sample was 
added to a 25 ml capacity vial containing distilled water. 
After putting the vial cap and applying the aluminium 
seal properly, the vial was shaken mechanically for 12 
hours at room temperature in an orbital flask shaker 
(Khera Instrument Pvt. Ltd., India). The vial was kept 
undisturbed for 24 hours. Then, the filtration was carried 
out using Whatmann filter paper # 41. The filtrate was 
appropriately diluted with distilled water and the 
absorbance was noted at 318 nm. The result of solubility 
was computed using the calibration curve. 
Then, the approximate solubility of drug was 
determined in PL 41 liquid. For this, 1 ml of PL 41 was 
taken in a 10 ml volumetric flask and the weight of this 
flask was noted. About 5 mg of drug was added in the 
volumetric flask and the flask was shaken to solubilize 
the drug. As soon as a clear solution was obtained, again 
about 5 mg of drug was transferred to the flask and the 
flask was shaken to solubilize the drug. Same procedure 
was repeated till the liquid PL 41 was nearly saturated 
with the drug (at this stage, slight turbidity was 
observed). Then, the final weight of the flask was noted. 
Difference in these two weights provided the 
approximate amount of drug solubilized by 1 ml of PL 
41. In this way, the approximate solubility of drug in PL 
41was determined. 
4. Proposed method of analysis 
For determination of drug content, twenty tablets of 
tablet formulation I were weighed accurately. With the 
help of pestle and mortar, the tablets were crushed to get 
a fine powder. The powder of tablets equivalent to 50 
mg tinidazole was transferred to a 500 ml volumetric 
flask. Ten ml of PL 41 liquid was added in the flask and 
the flask was shaken continuously for 10 minutes 
manually. This step ensured the complete dissolution of 
drug (present in the powder taken) in the 10 ml of PL 41 
liquid.  Then, 400 ml of distilled water was added in the 
flask and the flask was shaken for 5 minutes. This step 
helps to retain the drug (tinidazole), phenol and 
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lignocaine hydrochloride in the solution form. Then, the 
volume was made up to 500 ml with distilled water. 
After filtration through Whatmann filter paper # 41 
(discarding the first few ml of the filtrate), 10 ml of the 
filtrate was diluted with distilled water up to 50 ml and 
the absorbance was noted at 318 nm against the reagent 
blank. This procedure was applied thrice (n=3). Exactly 
the same procedure was used for assay of tablet 
formulation II. The drug contents were determined using 
the calibration curve and the results of analysis were 
recorded in Table 1.  
5. Recovery studies 
Recovery studies were performed on the pre-analyzed 
tablet powders. Standard tinidazole drug was added (15 
mg and 30 mg, separately) to the pre-analyzed tablet 
powder equivalent to 50 mg tinidazole and the drug 
content was determined by the proposed method. 
Results of analysis with statistical evaluation are 
reported in Table 2. 
 
Table 1: Analysis data of tinidazole tablet formulations with statistical evaluation (n=3) 
Tablet 
Formulation 
Label Claim 
(mg/tablet) 
Percent Drug Estimated 
(mean ± SD) 
Percent Coefficient 
of Variation 
Standard Error 
I 300 99.39 ± 1.424 1.433 0.822 
II 300 100.97 ± 1.807 1.790 1.043 
 
Table 2: Results of recovery studies with statistical evaluation (n=3) 
Tablet 
Formulation 
Drug in Pre-
Analyzed Tablet 
Powder (mg) 
Amount of 
Standard Drug 
Added (mg) 
% Recovery 
Estimated (mean 
± SD) 
Percent Coefficient 
of Variation 
Standard 
Error 
I 50 15 98.22±1.755 1.787 1.013 
I 50 30 99.84±1.421 1.423 0.820 
II 50 15 100.14±1.907 1.904 1.101 
II 50 30 98.84±1.423 1.440 0.822 
 
RESULTS AND DISCUSSION  
The results of solubility studies revealed that the 
equilibrium solubility of tinidazole in distilled water at 
room temperature was found to be 5.38 mg/ml while the 
approximate solubility of tinidazole drug in PL 41 liquid 
was found to be more than 200 mg/ml. 
Table 1 demonstrates that the percent drug estimated in 
tablet formulation I and formulation II were 99.39 ± 
1.424 and 100.97 ± 1.807, respectively. Since, these 
values are very close to 100; this indicates the accuracy 
of the proposed analytical method. Small values of 
statistical parameters, viz. standard deviations (1.424 
and 1.807 for tablet formulation I and formulation II, 
respectively), percent coefficient of variation (1.433 and 
1.790, for tablet formulation I and formulation II, 
respectively) and standard error (0.822 and 1.043, for 
tablet formulation I and formulation II, respectively) 
further validated the proposed analytical method. 
Further, Table 2 shows that the range of percent 
recoveries varied from 98.22±1.755 to 100.14±1.907. 
These values are again very close to 100, confirming the 
accuracy of the proposed method which is further 
supported by significantly small values of statistical 
parameters viz. standard deviation, percent coefficient of 
variation and standard error. 
CONCLUSION 
The proposed method is new, simple, environment 
friendly, accurate and reproducible. The proposed 
method can be successfully employed in the routine 
analysis of tinidazole tablets. The use of PL 41can also 
be done to estimate other water insoluble drugs which 
are estimated above 310 nm. Phenol and lignocaine 
hydrochloride do not interfere above 310 nm. Obtained 
accuracy of the proposed analytical method is also 
indicative of the proof that the solids possess solvent 
character. 
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